NSAID use and breast cancer risk in the VITAL cohort
- 201 Downloads
We prospectively evaluated the association between average 10-year use of NSAIDs and invasive breast cancer.
Between 2000–2002, 35,323 postmenopausal women participating in the Vitamins And Lifestyle (VITAL) study provided detailed information regarding NSAID use, lifestyle and breast cancer risk factors. Using a Cox proportional hazards model, we analyzed associations between NSAID use and incident breast cancer (N = 482) ascertained through linkage to the SEER cancer registry.
Use of low-dose aspirin at 4+ days/week over ten years was associated with a decreased risk of breast cancer (HR 0.65, confidence interval [CI] 0.43–0.97) versus no use, as was moderate use of other types of NSAIDs (HR 0.78, CI 0.61–0.98) for 10-yr average use up to 3 days/week. However, more frequent use of NSAIDs other than low–dose aspirin was associated with an increased risk (HR 1.26, CI 0.96–1.65), particularly frequent use of regular or extra strength aspirin (HR 1.43, CI 1.02–2.00).
We did not find evidence of a global protective effect of NSAID use for the development of breast cancer. However, long-term moderate use (frequent use of low doses or moderate frequency of high doses) was associated with reduced risk, while frequent use of higher dose products was associated with increased risk.
KeywordsAspirin Breast cancer Ibuprofen Non-steroidal anti-inflammatory drugs NSAIDs
This publication was made possible by grant CA74846 from the National Cancer Institute and T32-AT00815 from the National Center for Complementary and Alternative Medicine (NCCAM). The authors wish to acknowledge Alyson Littman for her guidance on statistical analysis, Alan Kristal for his useful input on analysis and interpretation and Ilonka Evans for her data management.
- 7.Asano TK, McLeod RS (2006) Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas. Cochrane Database Syst Rev 2Google Scholar
- 11.Johnson TW, Anderson KE, Lazovich D, Folsom AR (2002) Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. CEBP 11:1586–1591Google Scholar
- 14.Marshall SF, Bernstein L, Anton-Culver H et al (2005) Nonsteroidal anti-inflammatory drugs use and breast cancer risk by stage and hormone receptor status. J NCI 97(11):805–812Google Scholar
- 15.Jacobs EJ, Thun MJ, Connell CJ et al (2005) Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort. CEBP 14(1):261–264Google Scholar